Atrial Myxoma Presenting As a Cerebellar Stroke

Azhar Amir Hamzah, Ziyadi G, Zulkarnain H, Rahman MNG

Abstract


Primary tumors of the heart are rare. However, among them cardiac myxoma is the most common tumor accounting for half of the primary cardiac neoplasms. About 75% of cardiac myxomas are located in the left atrium, and 25% are located in the right atrium. These are thought to be arising from remnants of subendocardial vasoformative reserve cells or multipotential primitive mesenchymal cells in the fossa ovalis and surrounding endocardium, which can differentiate along a variety of cell lineages including epithelial, hematopoietic, and muscle cells. Although some cases are discovered incidentally by echocardiographic examination, it was recognized in most of the patients by various symptoms caused by the release of inflammatory cytokines such as interleukin-6 (IL-6), obstruction of intracardiac blood flow, or embolization. Cardiac myxoma has many undetermined interesting issues regarding its origin, nature as a tumor, varying clinical manifestations, and the presence of both sporadic and familial types. Recent evidence revealed that cardiac myxomas are benign neoplasms and slowly proliferating lesions. The existence of its malignant counterpart is controversial. However, recurrence after surgical excision or metastasis has been reported. We hereby present a case report of a young gentleman who presented with history of sudden onset of weakness and cerebellar signs. Urgent CT scan revealed hypodensities of bilateral occipital lobes and cerebellum suggestive of infarcts. Urgent echocardiography denoted large left atrial myxoma. The tumor was excised and the patient recovered well.

Keywords


Atrial myxoma, stroke, cerebellar signs, embolic phenomena

Full Text:

PDF

References


Reynen K. Cardiac myxomas. N Engl J Med 1995; 333(24):1610-7.

Blondeau P. Primary cardiac tumors: French studies of 533 cases. Thorac Cardivasc Surg 1990; 38(Suppl 2):192–5.

Molina JE, Edwards JE, Ward HB. Primary cardiac tumors: experience at the University of Minnesota. Thorac Cardivasc Surg 1990; 38 (Suppl 2): 183-91.

Centofanti P, Rosa ED, Deorsola L, et al. Primary cardiac tumors: early and late results of surgical treatment in 91 patients. Ann Thorac Surg 1999; 68(4): 1236-41.

Prichard RW. Tumors of the heart: review of the subject and report of one hundred and fifty cases. Arch Pathol 1951; 51:98-126.

Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine (Baltimore) 2001; 80(3):159–172.

Ng HK, Poon WS. Cardiac myxoma metastasizing to the brain: case report. J Neurosurg 1990; 72(2):295–298.

Chen HJ, Liou CW, Chen L. Metastatic atrial myxoma presenting as intracranial aneurysms with hemorrhage: case report. Surg Neurol 1993; 40(1):61–64.

Knepper LE, Biller J, Adams HP Jr, Bruno A. Neurologic manifestations of atrial myxoma. A 12-year experience and review. Stroke 1988; 19(11):1435–1440.

Alvarez-Sabin J, Lozano M, Sastre-Garriga J, et al. Transient ischaemic attack: a common initial manifestation of cardiac myxomas. Eur Neurol 2001; 45(3):165–170.

Kawamura T, Muratani H, Inamura T, et al. Serial MRI of cerebral infarcts before and after removal of an atrial myxoma. Neuroradiology 1999; 41(8):573–575.

Mugge A, Daniel WG, Haverich A, Lichtlen PR. Diagnosis of noninfective cardiac mass lesions by two-dimensional echocardiography: comparison of the transthoracic and transesophageal approaches. Circulation 1991; 83(1):70–78.

Mendoza CE, Rosado MF, Bernal L. The role of interleukin-6 in cases of cardiac myxoma. Clinical features, immunologic abnormalities, and a possible role in recurrence. Tex Heart Inst J 2001; 28(1):3-7.

Ha JW, Kang WC, Chung N, Chang BC, Rim SJ, Kwon JW, et al. Echocardiographic and morphologic characteristics of left atrial myxoma

and their relation to systemic embolism. Am J Cardiol 1999; 83(11):1579-82.

Moriyama Y, Saigenji H, Shimokawa S, Toyohira H, Taira A. the surgical treatment of 30 patients with cardiac myxomas: a comparison of clinical features according to morphological classification. Jpn J Surg 1994; 24(7):596-8.

Gray IR, Williams WG. Recurring cardiac myxoma. Br Heart J 1985; 53(6): 645-9.

Gerbode F, Kerth WJ, Hill JD. Surgical management of tumors of the heart. Surgery 1967; 61(1): 94-101.

Shinfeld A, Katsumata T, Westaby S. Recurrent cardiac myxoma: seeding or multifocal disease Ann Thorac Surg1998; 66(1): 285-8.

Dang CR, Hurley EJ. Contralateral recurrent myxoma of the heart. Ann Thorac Surg 1976; 21(1): 59–62.

Read RC, White HJ, Murphy ML, Williams D, Sun CN, Flanagan WH. The malignant potentiality of left atrial myxoma. J Thorac Cardiovas Surg 1974; 68(6): 857–68.

Wada A, Kanda T, Hayashi R, Imai S, Suzuki T, Murata K. Cardiac myxoma metastasized to the brain: potential role of endogenous interleukin-6. Cardiology 1993; 83(3): 208–11.


Refbacks

  • There are currently no refbacks.


e-issn 2231-7481